APOE and Alzheimer disease: Third, after excluding ε2/ε4 participants (because of the known protective effects of the ε2 allele), we observed an interaction DHA × APOE-ε4 carriership on incident AD and all-cause dementia, with a trend towards a greater benefit of DHA in ε4 carriers than in non-carriers.